DOCSLIB.ORG

A Documentation of Malaria Program Implementation in Burkina Faso Prepared by MCHIP/USAID in Collaboration with the National Malaria Control Program March 2013

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Documentation of Malaria Program Implementation in Burkina Faso Prepared by MCHIP/USAID in Collaboration with the National Malaria Control Program March 2013 A Documentation of Malaria Program Implementation in Burkina Faso Prepared by MCHIP/USAID in Collaboration with the National Malaria Control Program March 2013 This report was made possible by the generous support of the American people through the United States Agency for International Development (USAID), under the terms of the Leader with Associates Cooperative Agreement GHS-A-00-08-00002-00. The contents are the responsibility of the Maternal and Child Health Integrated Program (MCHIP) and do not necessarily reflect the views of USAID or the United States Government. The Maternal and Child Health Integrated Program (MCHIP) is the USAID Bureau for Global Health’s flagship maternal, neonatal and child health (MNCH) program. MCHIP supports programming in maternal, newborn and child health, immunization, family planning, malaria, nutrition, and HIV/AIDS, and strongly encourages opportunities for integration. Cross-cutting technical areas include water, sanitation, hygiene, urban health and health systems strengthening. Prepared by: Bill Brieger Ousmane Badolo Aisha Yansaneh Rachel Waxman Elaine Roman Published by: Jhpiego Brown’s Wharf 1615 Thames Street Baltimore, Maryland 21231-3492, USA www.jhpiego.org © Jhpiego Corporation, 2013. All rights reserved. Table of Contents ABBREVIATIONS AND ACRONYMS ........................................................................................................... vi ACKNOWLEDGMENTS ............................................................................................................................... v INTRODUCTION .......................................................................................................................................... 1 Background ........................................................................................................................................... 1 Epidemiological Profile of Malaria in Burkina Faso .............................................................................. 2 Endemicity ............................................................................................................................................ 2 Morbidity and Mortality ........................................................................................................................ 3 Malaria and HIV Interactions ............................................................................................................... 3 Progress on Malaria Indicators ............................................................................................................ 4 DOCUMENTATION METHODS .................................................................................................................... 6 STRATEGY AND POLICY DEVELOPMENT ................................................................................................... 7 Historical Development ......................................................................................................................... 7 Current Strategy for 2011–2015 ......................................................................................................... 9 Current Levels of Support ..................................................................................................................... 9 IMPLEMENTATION PROGRESS .............................................................................................................. 10 Case Management ............................................................................................................................. 11 Intermittent Preventive Treatment ..................................................................................................... 13 Vector Control ..................................................................................................................................... 14 Insecticide-Treated Nets ................................................................................................................... 14 Indoor Residual Spraying .................................................................................................................. 15 Larviciding .......................................................................................................................................... 16 Management of Supply of Commodities against Malaria ................................................................. 16 Advocacy, Information, Education, Communication and Social Mobilization ................................... 16 Epidemiological Surveillance, Monitoring, Evaluation and Research ............................................... 17 NMCP Program Management and Coordination ............................................................................... 17 SYSTEMS FACTORS INFLUENCING IMPLEMENTATION PROGRESS ..................................................... 19 Policy and Strategy Formulation and Dissemination ........................................................................ 19 Integration and Coordination with Relevant Primary Health Care Service Areas and Partners ...... 19 Reproductive and Maternal Health .................................................................................................. 19 HIV and AIDS ...................................................................................................................................... 20 Financial Sources and Adequacy ....................................................................................................... 21 Community Awareness and Involvement........................................................................................... 23 Commodities and Procurement ......................................................................................................... 25 A Documentation of Malaria Program Implementation in Burkina Faso iii Monitoring, Evaluation and Research ................................................................................................ 27 Routine Service Data ........................................................................................................................ 28 Other Data Sources ........................................................................................................................... 29 Research to Support Malaria Programming .................................................................................... 29 Capacity Building and Training ........................................................................................................... 31 In-Service Training ............................................................................................................................. 31 NMCP Capacity .................................................................................................................................. 31 Pre-Service Training .......................................................................................................................... 32 Quality Assurance including Supervision ........................................................................................... 33 Leadership, Governance and Structure ............................................................................................. 34 DISCUSSION ........................................................................................................................................... 35 Recommendations ............................................................................................................................. 39 REFERENCES/BIBLIOGRAPHY ............................................................................................................... 41 ANNEX 1: IDENTIFICATION DES MEMBRES DU PNLP (NMCP STAFF LIST) .......................................... 45 iv A Documentation of Malaria Program Implementation in Burkina Faso Acknowledgments The authors of this documentation thank the Ministry of Health of Burkina Faso and the National Malaria Control Program (NMCP) for their assistance and contributions. We also acknowledge the contributions of Dr. Patrice Combary, Coordinator of the NMCP, as well as Kathleen Webb and Dr. Victor Nana, U.S. Agency for International Development (USAID) Malaria Advisors. Staff from the following offices and organizations were central to informing this documentation: Program for Health Development (PADS) General Directorate of Health Protection, Ministry of Health of Burkina Faso General Directorate of Pharmacies, Medicines and Laboratories Directorate of Maternal and Child Health, Ministry of Health of Burkina Faso Directorate of Disease Control (DLM) Directorate of Public Hygiene and Health Education Directorate of Community Health Regional and District Health Directorates Ecole Nationale de la Santé Publique (National School of Public Health) Central Essential Medicines and Generic Drugs Purchasing Agency (CAMEG) USAID DELIVER PROJECT Abt Associates U.S. Peace Corps Plan Burkina United Nations Children’s Fund (UNICEF) World Health Organization A Documentation of Malaria Program Implementation in Burkina Faso v Abbreviations and Acronyms AB Accoucheuses Brevetées (Midwife) ACT Artemisinin-Based Combination Therapy ANC Antenatal Care ASC Agent de Santé Communautaire (Community Health Worker) BCC Behavior Change Communication CAMEG Centrale d’Achat des Médicaments Essentiels Génériques (Central Essential Medicines and Generic Drugs Purchasing Agency) CBO Community-Based Organization CCM Country Coordinating Mechanism CDC U.S. Centers
Load more

Recommended publications
  • Annual Meeting
    Volume 97 | Number 5 Volume VOLUME 97 NOVEMBER 2017 NUMBER 5 SUPPLEMENT SIXTY-SIXTH ANNUAL MEETING November 5–9, 2017 The Baltimore Convention Center | Baltimore, Maryland USA The American Journal of Tropical Medicine and Hygiene The American Journal of Tropical astmh.org ajtmh.org #TropMed17 Supplement to The American Journal of Tropical Medicine and Hygiene ASTMH FP Cover 17.indd 1-3 10/11/17 1:48 PM Welcome to TropMed17, our yearly assembly for stimulating research, clinical advances, special lectures, guests and bonus events. Our keynote speaker this year is Dr. Paul Farmer, Co-founder and Chief Strategist of Partners In Health (PIH). In addition, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, will deliver a plenary session Thursday, November 9. Other highlighted speakers include Dr. Scott O’Neill, who will deliver the Fred L. Soper Lecture; Dr. Claudio F. Lanata, the Vincenzo Marcolongo Memorial Lecture; and Dr. Jane Cardosa, the Commemorative Fund Lecture. We are pleased to announce that this year’s offerings extend beyond communicating top-rated science to direct service to the global community and a number of novel events: • Get a Shot. Give a Shot.® Through Walgreens’ Get a Shot. Give a Shot.® campaign, you can not only receive your free flu shot, but also provide a lifesaving vaccine to a child in need via the UN Foundation’s Shot@Life campaign. • Under the Net. Walk in the shoes of a young girl living in a refugee camp through the virtual reality experience presented by UN Foundation’s Nothing But Nets campaign.
    [Show full text]
  • Maternal Mortality and HIV: an Overview
    Maternal Mortality and HIV: An Overview Contextual factors such as local policies and cultural norms, as well as socioeconomic factors, play a role in women’s ability to access care and receive appropriate treatment during pregnancy, childbirth, and postpartum.1 This is true for all women, and particularly so for the 17 million women living with HIV globally, the vast majority of whom live in sub-Saharan Africa (SSA) and are of reproductive age.2 In 2013, HIV was responsible for 1.5% of all maternal Adult HIV prevalence rates, 2012 data from Global Report: UNAIDS Report on the Global AIDS Epidemic 2013. deaths in SSA and 0.4% worldwide.3 Pregnant women living with HIV have between a two to 10 times increased risk of death than uninfected pregnant women.4,5,6,7,8 While maternal deaths have decreased overall in the past decade, countries with high HIV burdens have had slower declines compared to countries less affected by the HIV pandemic. For example, South Africa—an upper middle-income country with an HIV infection rate among pregnant women aged 15-49 years of 29.5%9—experienced a decrease of only 0.4% in its maternal mortality ratio (MMR) between 1990 and Data on maternal mortality ratio (per 100,000 live births) from World 2013, despite a global MMR decrease of 45% in the Health Organization 2012. same timeframe10. CAUSES OF MATERNAL MORBIDITY AND MORTALITY AMONG WOMEN LIVING WITH HIV The World Health Organization (WHO) defines maternal death as “the death of a woman during pregnancy or within 42 days of termination of pregnancy irrespective
    [Show full text]
  • Introduction to the Maternal and Newborn Quality of Care Surveys
    INTRODUCTION TO THE MATERNAL AND NEWBORN QUALITY OF CARE SURVEYS Introduction To The Quality of Care Surveys i The Maternal and Child Health Integrated Program (MCHIP) is the United States Agency for International Development’s Bureau for Global Health flagship maternal, neonatal and child health program. MCHIP supports programming in maternal, newborn and child health, immunization, family planning, malaria and HIV/AIDS, and strongly encourages opportunities for integration. Cross-cutting technical areas include water, sanitation, hygiene, urban health and health systems strengthening. This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID), under the terms of the Leader with Associates Cooperative Agreement GHS-A-00-08-00002-00. The contents are the responsibility of the Maternal and Child Health Integrated Program (MCHIP) and do not necessarily reflect the views of USAID or the United States Government. Published by: Jhpiego Brown’s Wharf 1615 Thames Street Baltimore, Maryland 21231-3492, USA January 2013 Introduction To The Quality of Care Surveys ii 1. BACKGROUND Improving the quality of obstetric care in facilities has recently been identified as a neglected and essential approach to reducing maternal deaths and enabling developing countries to achieve Millennium Development Goal (MDG) 4 and 5.1 Postpartum hemorrhage is the most frequent cause of maternal deaths globally and in developing countries, accounting for 25% of maternal deaths. Next are hypertensive disorders in pregnancy (PE/E) at 15%, sepsis (8%) and obstructed labor (7%).2 Effective interventions exist for screening, preventing and treating obstetric and newborn complications, and they can be readily provided by skilled providers in facilities.
    [Show full text]
  • The Silk Road
    The Silk Road Volume 1 Number 1 January 15, 2003 第1卷 第1號 “The Bridge between Eastern and Western Cultures” 一月十五日 In This Issue • WELCOME TO THE FIRST ISSUE WELCOME TO THE FIRST ISSUE! • [email protected]: A YE- Since the Soviet collapse, the nations of Central One reason for our distorted image of Central MENI TRADING LINK THREE THOUSAND Asia have shaken off imposed obscurity to make Asia has been the diffi culty of access for west- YEARS OLD headlines of their own. The emergence of these ern travelers, scholars, and archaeologists. new states has helped to focus attention once Russian and Chinese investigators working in • THE ORIGIN OF CHESS AND THE SILK again on their history, culture, and people. For their respective languages have done most of ROAD most of us, these were places whose names we the fi rst hand observation and reporting. The barely knew a decade ago. Collectively more experienced fi eld archaeologists • THE MONGOLS AND THE SILK ROAD they form the heart of Eurasia. Today in Russia and China—Elena Kuzmina • AGE OF MONGOLIAN EMPIRE: A BIB- they may be known as Ukraine, Armenia, from Moscow and Wang Binghua from LIOGRAPHICAL ESSAY Georgia, Azerbaijan, Turkmenistan, Urumchi, for example—have more di- Kazakhstan, Tajikistan, Uzbekistan, and rect experience with Central Asian sites Kyrghizstan, but in the more remote and materials than practically all of past, along with Afghanistan, Xinjiang, the American investigators combined. and Gansu, they evoked images of the an- Their reports and publications, in Russian and cient Silk Road—oases, caravanserai, nomads, Chinese, are available in the west to only a lim- strange empires, fantastic beasts, and exotic ited number of specialists.
    [Show full text]
  • Next-Generation Lab-On-A-Chip Devices
    Next-generation lab-on-a-chip devices Samuel Sia, Ph.D. Associate Professor Department of Biomedical Engineering Columbia University APHL, Little Rock June 4, 2014 Clinical ELISA testing... ELISA ideal method low cost? - capital -per test compact? rapid? simple to operate? sensitive (pM)? distinguishes quantitative differences? amenable to parallel analysis? operable without ground electricity? works in field conditions (sunlight)? • coat surface with antigen (overnight) • block with 1% BSA or 0.05% Tween-20 (1 hr) uses accessible • add sample containing antibody to be tested (1 hr) reagents? • add enzyme-conjugated antibody (1 hr) • add substrate (10 min.) “Plug-in cartridge” (bubble-based reagent delivery) 17 pM 170 pM 1.7 nM 17 nM 170 nM 1.7 M Fluorescent antibody Sample Wash Wash Fluorescent Air spacers antibody 200 m Vacuum Antibody in sample Antigen 1200 1000 800 500-m 600 width 250-m 400 50-m width width total time = 2 min. 200 500-m (hands-free) width 0 Normalized fluorescence (a.u.) fluorescence Normalized 0.1 10 1000 Concentration of anti-rabbit IgG (nM) Linder, Sia, and Whitesides, Anal. Chem., 77:64 (2005) Silver reduction enables the use of microfluidics Angew Chemie, 43:498 (2004) ELISA mChip signal generation enzyme/substrate silver precipitation reaction (photography) light source lasers, lenses, filters LEDs (ambient lighting) detector photomultiplier tubes photodetector (photocopier) manufacturing plastic 96-well plates injection-molded plastic (consumer toys) Point-of-care ELISA Founded in 2004 (with Vincent Linder and David Steinmiller), based in Boston area raised ~$12M in VC funding First product: prostate cancer monitoring ISO-certified manufacturing facility and clean room approved in Europe (CE Mark) acquired by Opko Health in 2011 (~$50M) awaiting FDA approval and launch of PSA test and eventually 4K panel (total PSA, free PSA, intact PSA, HK2) Clinical scenario Pregnant woman in high burden-of-disease area (health clinic in U.S.
    [Show full text]
  • Principle of Infection
    23/09/56 Principle of Infection La-or Chompuk, M.D. Department of pathology Faculty of Medicine Infection • Definition: Invasion and multiplication of microorganisms in body tissues • No symptom, local cellular injury, localized symptom, dissemination • Mechanism; competitive metabolism, toxins, intracellular replication, immune response 1 23/09/56 Classification of infectious agents: - classification according to structure - classification according to pathogenesis - classification according to site of multiplication Classification according to structure - Prion - Fungi - Viruses - Protozoa, metazoa - Bacteria - Ectoparasite - Rickettsia, chlamydia, mycoplasma 2 23/09/56 Classification according to pathogenesis • Pathogenic agents; - Virulence: the degree of pathogenicity of a microorganism - Indicated by the severity of disease, the ability to invade tissue - high virulence - low virulence • Opportunistic infection Classification according to site of multiplication - obligate intracellular organisms; Prions, viruses, rickettsiae, chlamydia, some protozoa - facultative intracellular organism; Mycobacteria, Actinomyces, Pseudomonas spp. - extracellular organisms; mycoplasma, fungi, bacteria, metazoa 3 23/09/56 Pathogenesis of Infectious Disease -Host - Pathogen; organism or parasite that cause disease Host factors: 1. General factors; socioeconomic status, behavior pattern, occupational, and internal factors 2. Natural defense mechanism; skin and normal flora, respiratory tract and mucociliary mechanism, Hcl production in stomach, or
    [Show full text]
  • Prevention and Control of Malaria in Pregnancy in the African Region
    P R E V E N T I O N A N D C O N T R O L O F M A L A R I A I N PREGNANC Y I N THE A FRIC AN R EGION A Program Implementation Guide P R E V E N T I O N A N D C O N T R O L O F M A L A R I A I N PREGNANC Y I N THE A FRIC AN R EGION A Program Implementation Guide For information: Jhpiego 1615 Thames Street Baltimore, MD 21231-3492, USA Tel: 410.537.1800 www.jhpiego.org Editor: Ann Blouse Graphic Design: Trudy Conley The ACCESS Program is the U.S. Agency for International Developments global program to improve maternal and newborn health. The ACCESS Program works to expand coverage, access and use of key maternal and newborn health services across a continuum of care from the household to the hospitalwith the aim of making quality health services accessible as close to the home as possible. Jhpiego implements the program in partnership with Save the Children, the Futures Group, the Academy for Educational Development, the American College of Nurse- Midwives and IMA World Health. www.accesstohealth.org Jhpiego is an international, non-profit health organization affiliated with The Johns Hopkins University. For nearly 40 years, Jhpiego has empowered front-line health workers by designing and implementing effective, low-cost, hands-on solutions to strengthen the delivery of health care services for women and their families. By putting evidence-based health innovations into everyday practice, Jhpiego works to break down barriers to high-quality health care for the worlds most vulnerable populations.
    [Show full text]
  • Equity Matters: Lessons from MCHIP and CSHGP in Measuring and Improving Equity
    Equity Matters: Lessons from MCHIP and CSHGP in Measuring and Improving Equity June 2014 Authors: Jennifer Winestock Luna Tanvi Monga Lindsay Morgan Suggested citation: Winestock Luna J, Monga T, and Morgan L. 2014. Equity Matters – Lessons from MCHIP and CSHGP in Measuring and Improving Equity. Maternal Child Health Integrated Program. This report was made possible by the generous support of the American people through the United States Agency for International Development (USAID), under the terms of the Leader with Associates Cooperative Agreement GHS-A-00-08-00002-00. The contents are the responsibility of the Maternal and Child Health Integrated Program (MCHIP) and do not necessarily reflect the views of USAID or the United States Government. The Maternal and Child Health Integrated Program (MCHIP) is the USAID Bureau for Global Health’s flagship maternal, neonatal and child health (MNCH) program. MCHIP supports programming in maternal, newborn and child health, immunization, family planning, malaria, nutrition, and HIV/AIDS, and strongly encourages opportunities for integration. Cross-cutting technical areas include water, sanitation, hygiene, urban health and health systems strengthening. www.mchip.net Table of Contents ABBREVIATIONS AND ACRONYMS ......................................................................................................... iv INTRODUCTION ....................................................................................................................................... 1 CONTRIBUTIONS BY MCHIP AND
    [Show full text]
  • Reaching Underserved Populations: Leveraging Point-Of-Care Tests for Sexually Transmitted and Blood-Borne Infections to Explore New Program Options in Canada
    Reaching Underserved Populations: Leveraging Point-of-Care Tests for Sexually Transmitted and Blood-Borne Infections to Explore New Program Options in Canada Review of the Evidence March, 2018 Prepared by Megan Smallwood, MSc, Reaching Underserved populations: Leveraging Point-of-Care Tests for Sexually Transmitted and Blood-Borne Infections to Explore New Program Options in Canada Review of the Evidence March, 2018 Prepared by Megan Smallwood, MSc Contact us at: National Collaborating Centre for Infectious Diseases Rady Faculty of Health Sciences, University of Manitoba Tel: (204) 318‐2591 Email: [email protected] www.nccid.ca This is NCCID Project number 382 Production of this document has been made possible through a financial contribution from the Public Health Agency of Canada through funding for the National Collaborating Centre for Infectious Diseases. The views expressed herein do not necessarily represent the views of the Public Health Agency of Canada. Table of Contents Introduction .................................................................................................................................................. 1 Sexually Transmitted and Blood‐borne Infections (STBBIs) in Canada ..................................................... 1 Point‐of‐Care Diagnostics ......................................................................................................................... 2 Aim of this Evidence Review ....................................................................................................................
    [Show full text]
  • TME Volume 7, Numbers 2 and 3
    The Mathematics Enthusiast Volume 7 Number 2 Numbers 2 & 3 Article 21 7-2010 TME Volume 7, Numbers 2 and 3 Follow this and additional works at: https://scholarworks.umt.edu/tme Part of the Mathematics Commons Let us know how access to this document benefits ou.y Recommended Citation (2010) "TME Volume 7, Numbers 2 and 3," The Mathematics Enthusiast: Vol. 7 : No. 2 , Article 21. Available at: https://scholarworks.umt.edu/tme/vol7/iss2/21 This Full Volume is brought to you for free and open access by ScholarWorks at University of Montana. It has been accepted for inclusion in The Mathematics Enthusiast by an authorized editor of ScholarWorks at University of Montana. For more information, please contact [email protected]. The Montana Mathematics Enthusiast ISSN 1551-3440 VOL. 7, NOS 2&3, JULY 2010, pp.175-462 Editor-in-Chief Bharath Sriraman, The University of Montana Associate Editors: Lyn D. English, Queensland University of Technology, Australia Simon Goodchild, University of Agder, Norway Brian Greer, Portland State University, USA Luis Moreno-Armella, Cinvestav-IPN, México International Editorial Advisory Board Mehdi Alaeiyan, Iran University of Science and Technology, Iran Miriam Amit, Ben-Gurion University of the Negev, Israel Ziya Argun, Gazi University, Turkey Ahmet Arikan, Gazi University, Turkey. Astrid Beckmann, University of Education, Schwäbisch Gmünd, Germany Raymond Bjuland, University of Stavanger, Norway Morten Blomhøj, Roskilde University, Denmark Robert Carson, Montana State University- Bozeman, USA Mohan Chinnappan,
    [Show full text]
  • Performing Place at Ancient Idalion, Cyprus: an Anthropological Perspective on the Lower City South Sanctuary Architecture Rebecca M
    University of Massachusetts Amherst ScholarWorks@UMass Amherst Cultural Heritage in European Societies and Spaces CHESS Student Research Reports (CHESS) 2013 Performing Place at Ancient Idalion, Cyprus: An Anthropological Perspective on the Lower City South Sanctuary Architecture Rebecca M. Bartusewich [email protected] Follow this and additional works at: https://scholarworks.umass.edu/chess_student_research Part of the Archaeological Anthropology Commons Bartusewich, Rebecca M., "Performing Place at Ancient Idalion, Cyprus: An Anthropological Perspective on the Lower City South Sanctuary Architecture" (2013). CHESS Student Research Reports. 11. Retrieved from https://scholarworks.umass.edu/chess_student_research/11 This Article is brought to you for free and open access by the Cultural Heritage in European Societies and Spaces (CHESS) at ScholarWorks@UMass Amherst. It has been accepted for inclusion in CHESS Student Research Reports by an authorized administrator of ScholarWorks@UMass Amherst. For more information, please contact [email protected]. Performing Place at Ancient Idalion, Cyprus: an anthropological perspective on the Lower City South sanctuary architecture Rebecca M. Bartusewich PhD Student University of Massachusetts Amherst1 Abstract: The ancient site of the Lower City South sanctuary of Idalion is a site of place making and identity formation during the 1st millennium BCE of Cyprus. This archaeological site represents repetitive building patterns and persistent cultic activity that denote a cultural tradition that withstood the changes of administrative control in the Cypro-Classical and Hellenistic periods. Certain architectural elements, like altars and water features, are characteristic of a continued tradition at the ancient site and they are evidence of a recursive building practice that falls into templates of place making and identity formation as introduced by Bourdieu and Giddens.
    [Show full text]
  • Parasites in Liver & Biliary Tree
    Parasites in Liver & Biliary tree Luis S. Marsano, MD Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Louisville & Louisville VAMC 2011 Parasites in Liver & Biliary Tree Hepatic Biliary Tree • Protozoa • Protozoa – E. histolytica – Cryptosporidiasis – Malaria – Microsporidiasis – Babesiosis – Isosporidiasis – African Trypanosomiasis – Protothecosis – S. American Trypanosomiasis • Trematodes – Visceral Leishmaniasis – Fascioliasis – Toxoplasmosis – Clonorchiasis • Cestodes – Opistorchiasis – Echynococcosis • Nematodes • Trematodes – Ascariasis – Schistosomiasis • Nematodes – Toxocariasis – Hepatic Capillariasis – Strongyloidiasis – Filariasis Parasites in the Liver Entamoeba histolytica • Organism: E. histolytica is a Protozoa Sarcodina that infects 1‐ 5% of world population and causes 100000 deaths/y. – (E. dispar & E. moshkovskii are morphologically identical but only commensal; PCR or ELISA in stool needed to differentiate). • Distribution: worldwide; more in tropics and areas with poor sanitation. • Location: colonic lumen; may invade crypts and capillaries. More in cecum, ascending, and sigmoid. • Forms: trophozoites (20 mcm) or cysts (10‐20 mcm). Erytrophagocytosis is diagnostic for E. histolytica trophozoite. • Virulence: may increase with immunosuppressant drugs, malnutrition, burns, pregnancy and puerperium. Entamoeba histolytica • Clinical forms: – I) asymptomatic; – II) symptomatic: • A. Intestinal: – a) Dysenteric, – b) Nondysenteric colitis. • B. Extraintestinal: – a) Hepatic: i) acute
    [Show full text]